Discussion
Diagnosis With Brief Discussion
- Diagnosis
- PPFE (pleuroparenchymal fibroelastosis)
- Radiologic Findings
- Non contrast enhanced chest CT scan shows pleural thickening in both upper thorax with subpleural fibrosis.
After about 4 years, non contrast enhanced chest CT scan shows progression of pleural thickening in both upper and extent to mid thorax with subpleural fibrosis and reticulation. And new findings are seen such as right fissural thickening, mild left fissural thickening, mild interlobular septal thickening in BLL.
- Brief Review
- Pleuroparenchymal fibroelastosis (PPFE) is an entity characterized by pleural and subpleural parenchymal fibrosis. It is extremely rare and was first described in 2004 by the Interstitial Lung Disease Program of the National Jewish Medical and Research Center of Denver.
Marked apical pleural thickening associated with superior hilar retraction is present at chest
X ray analysis, and High Resolution Computed Tomography (HRCT) shows pleural thickening, fibrosis, architectural distortion, traction bronchiectasis and honeycomb lung. The clinical course of this affection is progressive and prognosis is poor.
The etiology of PPFE is considered idiopathic in most cases, an association with a wide range of factors has been reported such as genetic predisposition
Chest radiographs in all cases showed marked apical pleural thickening, which was associated with superior hilar retraction.
HRCT images show dense pleural and subpleural consolidation with a reticular pattern, predominantly in the upper lobes. The upper lobes were always more severely involved, with involvement of the lower lobes being absent or less marked (apicocaudal distribution). Associated features included upper lobe volume loss, architectural distortion and traction bronchiectasis. One of the patients showed significant worsening relative to previous examinations. Two of the patients showed reticular opacities with some
areas of honeycombing and traction bronchiectasis. The other patient had co-existent cystic bronchiectasis. The patients underwent a TTB in the higher density
zones. All the patients were complicated with mild to moderate iatrogenic pneumothoraxes. Placement of a chest tube was needed in three patients. The pneumothorax resolved completely before discharge with a hospital stay ranging between 1 day and 17 days. One of the patients was also complicated with subcutaneous emphysema.
The therapeutic approach is highly variable in the published clinical cases with no clearly definitive therapeutic options other than lung transplantation. Disease progression occurs in 60 % of patients with death from disease in 40 %.
The differential diagnosis of PPFE includes asbestosis, connective tissue diseases, advanced fibrosing sarcoidosis and radiation or drug induced lung disease.
- References
- 1. Sara Piciucchi, Sara Tomassetti, Gianluca Casoni, Nicola Sverzellati, Angelo Carloni, Alessandra Dubini, Giampaolo Gavelli, Alberto Cavazza, Marco Chilosi and Venerino Poletti, “High resolution CT and histological findings in idiopathic pleuroparenchymal fibroelastosis: features and differential diagnosis” Respir. Res. 2011;12 (1): 111
2. Cátia Esteves, Francisco R. Costa, Margarida T. Redondo, Conceição S. Moura, Susana Guimarães, António Morais, José M. Pereira “Pleuroparenchymal fibroelastosis: role of high-resolution computed tomography (HRCT) and CT-guided transthoracic core lung biopsy” Insights Imaging (2016) 7:155–162
3. Stephen K. Frankel, Carlyne D. Cool, David A. Lynch, and Kevin K. Brown. “Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity” Chest. 2004;126 (6): 2007-13
4. Taryn L. Reddy, Masaki Tominaga, David M. Hansell, Jan von der Thusen, Doris Rassl, Helen Parfrey, Suzy Guy, Orion Twentymane, Alexandra Rice, Toby M. Maher, Elisabetta A. Renzoni, Athol U.Wells and AndrewG.Nicholson. “Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes”. Eur Respir J 2012; 40: 377–385
- Keywords
- lung, idiopathic interstitial lung disease, pleuroparenchymal fibroelastosis,